Biotech · Private company
SetPoint Medical Corporation
Track this companyFree. Adds SetPoint Medical Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Active stimulationPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Conventional Synthetic DMARDPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Implant ProcedurePhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Non-active stimulationPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Active stimulationRelapsing Remitting Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Disease-Modifying Therapies (DMTs)Relapsing Remitting Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Implant ProcedureRelapsing Remitting Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- Non-active stimulationRelapsing Remitting Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- SetPoint Medical Neurostimulation of the Cholinergic Anti-inflammatory Pathway SystemRheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyNA · RECRUITING · started Apr 17, 2026ClinicalTrials.gov NCT06796504 · fetched Nov 12, 2026
- Vagus Nerve Stimulation for Moderate to Severe Rheumatoid ArthritisPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 11, 2021ClinicalTrials.gov NCT04539964 · fetched Nov 12, 2026
- Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)NA · ACTIVE_NOT_RECRUITING · started Jul 28, 2018ClinicalTrials.gov NCT04862117 · fetched Nov 12, 2026